5Jonsson M V,Szodoray P,Jellestad S,et al.Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome. Clin Immunol,2005,25(3):189-201.
6Vitali C,Bombardieri S,Jonsson R,et al.The European Study Group on Classification Criteria for Sjogren's Syndrome.Classification criteria for Sjogren's syndrome European Consensus Group.Ann Rheum Dis,2002,61:554-558.
7Pijpe J,Imhoff G W,Spijkervet F K,et al.Rituximab treatment in patients with primary Sjogren's syndrome:an open-label phase IIE study.Ar-thritis Rheum,2005,52(9):2740-2750.
8Pratuzmnab Steinfeld S D,Tant L,Burmester G R,et al.Humanised anti-CD22 antibody in primary Sjogrens syndrome:an open-label- phase I/II study.Arthritis Res Ther,2006,8(4): 129.
